Executive Vice President · IDEXX Laboratories Inc (IDXX)

Jay Mazelsky

A named executive officer of IDEXX Laboratories in every fiscal year CompBrief holds from FY2016 to FY2018. Every figure below is printed as the company filed it and cited to the filing it came from.

Total disclosed compensation, FY2018

$2,897,125

Salary $555,385Stock awards $449,928

FY2017: $2,269,833

3rd of 5 named executive officers at Idexx Laboratories by FY2018 total.

5 named officers on file for IDEXX Laboratories, FY2018

Jay Mazelsky’s pay file — $29

  • 3 fiscal years of pay, line by line
  • 2 equity grants, each cited to its filing
  • IDXX’s disclosed peer group of 16 companies

A PDF and a CSV sent to your email. Every row is cited to its filing.

One-time report. No refunds.

See an example →

Velarion Intel · free for 3 days · no card

See how IDEXX Laboratories’s whole pay program stands against its peers

  • IDEXX Laboratories’s company dashboard and its AI-written, board-ready brief, every figure cited to the filing
  • Peer-group intelligence, custom peer reruns and governance screens
  • Every other company we cover, with alerts when they file
Start my free trial on IDXX→

No card. Nothing is charged, and the trial ends on its own.

Compensation figures as of the proxy filed March 25, 2019 (DEF 14A).

Free

Get Jay Mazelsky’s pay history as a PDF, right here and by email

The PDF adds what this page leaves out: up to 10 years of pay, a peer comparison, and the board on one page. Two emails at most, nothing else.

Jay Mazelsky compensation by year

IDEXX Laboratories Summary Compensation Table · all 3 fiscal years held
In US dollars, as IDEXX Laboratories reports it. Most recent year shaded. Totals are the company’s disclosed totals.
ComponentFY2016FY2017FY2018
Salary$447,969$469,462$555,385
Bonus$0$0$0
Stock awards$250,027$324,972$449,928
Option awards$749,542$973,510$1,348,870
Non-equity incentive$600,000$479,000$517,500
Pension and deferred compensation$0$0$0
All other$22,625$22,889$25,442
Total$2,070,163$2,269,833$2,897,125

Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: IDEXX Laboratories Inc DEF 14A filed March 25, 2019, accession 0000874716-19-000013, and prior-year filings.

How this page was built: the IDEXX Laboratories Inc filed document, accession 0000874716-19-000013. Every figure is read from that document and cited to the page and table it appears in. Filed March 25, 2019.

$2.1M
$2.3M
$2.9M
FY16
FY17
FY18
SalaryNon-equity incentiveStock awardsOption awardsAll other

Equity holdings

unvested awards at FY2018 year-end
TypeUnvested unitsValue at year-endExercise price
RSU2,524$469,514—
RSU2,211$411,290—
RSU1,836$341,533—
RSU942$175,231—
RSU403$74,966—
Option4,122—$62.00
Option25,700—$178.26
Option19,225—$141.60
Option11,240—$79.54
Option25,641—$67.85

Per the Outstanding Equity Awards at Fiscal Year-End table in IDEXX Laboratories Inc's FY2018 proxy; value at the fiscal year-end close, as the company printed it.

IDEXX Laboratories’s named executive officers, FY2018

as the company reported each
Named executive officerRoleFY2018 total
Jonathan AyersPresident and Chief Executive Officer$6,819,950
Brian McKeonExecutive Vice President, Chief Financial Officer and Treasurer$2,905,934
Jay Mazelsky · this pageExecutive Vice President$2,897,125
Kathy TurnerCorporate Vice President$1,935,853
Michael LaneCorporate Vice President$1,357,675

The full IDEXX Laboratories compensation record

free company brief

This page is one person within IDEXX Laboratories's record. The company brief lists every named executive, each linking to their own page.

Peer companies

named in the IDEXX Laboratories proxy · each links to its own free brief

Compensation, the day it’s disclosed

The CompBrief Daily Digest lists the newest executive and director compensation disclosures as companies file them.

How this record is built

Every figure on this page is one figure from a public SEC filing, printed as the filing states it and cited to the document. Compensation totals are IDEXX Laboratories's own disclosed totals, not summed by Velarion. Insider transactions are read from Form 4 filings and cover every line filed since the most recent proxy. Nothing is estimated by Velarion; where the company does not disclose a value the cell reads "—", and a section appears only where the company discloses the data. Corrections: records@velarion.ai.

Jay Mazelsky's compensation dossier · One-time report. No refunds.